ArticleFrontiers in endocrinology2026
Association of the new TyG indicator-TyHGB with prediabetes and diabetes in middle-aged and elderly postmenopausal women: a longitudinal study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Given the established relationship between lipid metabolism and dysglycemia, this longitudinal study aimed to investigate the association between the triglyceride-high density lipoprotein cholesterol-glucose body index (TyHGB) and the risk of developing prediabetes or diabetes among middle-aged and elderly postmenopausal women. Methods: Data were collected from the REACTION study in Dalian, China. The study included postmenopausal women with normal baseline glucose tolerance who were followed up over a three-year period. We used multivariable logistic regression to evaluate the relationship of TyHGB with incident prediabetes and diabetes. Restricted cubic splines (RCS) were employed to examine dose-response relationships. The predictive performance of TyHGB and traditional indices for prediabetes and diabetes was evaluated and compared using receiver operating characteristic (ROC) curve analysis. Results: Among the 2,138 postmenopausal women with normal glucose levels at baseline, 598 developed prediabetes and 124 developed diabetes during the follow-up period. Multivariable logistic regression revealed a significant positive association between TyHGB and the risk of both prediabetes and diabetes. Restricted cubic spline analysis confirmed a nonlinear dose-response relationship, with prediabetes risk increasing steeply below an inflection point of 8.52 before plateauing, whereas diabetes risk remained stable below 6.47 and increased sharply thereafter. Subgroup analyses demonstrated that this association remained consistent across strata defined by age, hypertension, hyperlipidemia, and coronary heart disease (CHD). Additional ROC curve analyses suggested that TyHGB may provide effective predictive value for diabetes in postmenopausal women. Conclusion: In a middle-aged and elderly postmenopausal population, the TyHGB index is a significant independent risk factor for prediabetes and diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.